Genentech, SanegeneBio Launch Up-to-$1.7B RNAi Collaboration
A SanegeneBio researcher at work in the company’s lab. Genentech, a member of the Roche Group, will apply…
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
Basilea Pharmaceutica International Ltd, Allschwil Funding is awarded following successful completion of IND-enabling studies and clinical study authorization …
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer’s Disease
ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ — SciNeuro Pharmaceuticals Logo (PRNewsfoto/SciNeuro Pharmaceuticals) SciNeuro grants Novartis an exclusive worldwide…
MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies
CHICAGO, June 18, 2025–(BUSINESS WIRE)–MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted…
Unnatural Products and Novartis Sign Heart Therapy
Editorial & Advertiser disclosure Global Banking & Finance Review® is an online platform offering news, analysis, and opinion…